Bull
$1.48
Precio del escenario
$0.380
+0.008 (+2.07%)Al cierre
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
IINN is not a good buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock is in a weak pre-market position at 0.3967, below key resistance and near support, with bearish trend signals dominating. With no bullish proprietary signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot to support a growth case, the setup does not justify an immediate purchase. Given the user's impatience and desire to act now, the direct answer is to avoid buying and wait.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

QTREX Unveils Ultra-High-Density Interconnect Architecture for Quantum Computing

QTREX Unveils Ultra-High-Density Interconnect Architecture for Quantum Computing

QTREX Quantum Secures $10 Million in Direct Offering

QTREX Quantum Ltd. Advances Quantum Computing with New Technology

QTREX Quantum Platform Exceeds Performance Requirements Set by Strategic Partners
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
IINN is not a good buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock is in a weak pre-market position at 0.3967, below key resistance and near support, with bearish trend signals dominating. With no bullish proprietary signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot to support a growth case, the setup does not justify an immediate purchase. Given the user's impatience and desire to act now, the direct answer is to avoid buying and wait.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.